Clinical trials recruiting for Adenocarcinoma of the Pancreas
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Nab-paclitaxel | 2 |
| Capecitabine | 1 |
| Cemiplimab | 1 |
| Cisplatin | 1 |
| Gemcitabine | 1 |
| Gemcitabine 1000 mg | 1 |
| Motixafortide | 1 |
| Simvastatin 20mg | 1 |
| Valproic acid | 1 |
| intraportal islet autotransplantation | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 1 |
| Rhode Island | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
- Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
- The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
- Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
Related conditions
Trials recruiting for Adenocarcinoma of the Pancreas often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Adenocarcinoma of the Pancreas trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.